ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 69 filers reported holding ONCTERNAL THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,795 | -13.0% | 39,318 | 0.0% | 0.00% | – |
Q2 2023 | $13,565 | -56.0% | 39,318 | +0.0% | 0.00% | – |
Q1 2023 | $30,863 | -21.5% | 39,316 | 0.0% | 0.00% | – |
Q4 2022 | $39,316 | +12.3% | 39,316 | -0.3% | 0.00% | – |
Q3 2022 | $35,000 | -20.5% | 39,436 | 0.0% | 0.00% | – |
Q2 2022 | $44,000 | -20.0% | 39,436 | +0.3% | 0.00% | – |
Q1 2022 | $55,000 | -38.9% | 39,316 | -0.3% | 0.00% | – |
Q4 2021 | $90,000 | -51.1% | 39,436 | -10.4% | 0.00% | – |
Q3 2021 | $184,000 | +67.3% | 44,036 | +90.6% | 0.00% | – |
Q2 2021 | $110,000 | -81.0% | 23,099 | -66.8% | 0.00% | -100.0% |
Q1 2021 | $579,000 | +6.6% | 69,647 | -37.1% | 0.00% | 0.0% |
Q4 2020 | $543,000 | -34.5% | 110,727 | -77.3% | 0.00% | -50.0% |
Q3 2020 | $829,000 | -40.1% | 487,737 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $1,385,000 | -3.1% | 487,737 | 0.0% | 0.00% | -20.0% |
Q1 2020 | $1,429,000 | -24.2% | 487,737 | +2.2% | 0.01% | -16.7% |
Q4 2019 | $1,886,000 | -21.0% | 477,445 | 0.0% | 0.01% | -25.0% |
Q3 2019 | $2,387,000 | – | 477,445 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Richmond Brothers, Inc. | 494,042 | $148,212 | 0.28% |
Quantum Private Wealth, LLC | 459,187 | $137,757 | 0.07% |
Pasadena Private Wealth, LLC | 278,750 | $83,625 | 0.02% |
Beta Wealth Group, Inc. | 32,000 | $9,600 | 0.01% |
BRIGHTON JONES LLC | 338,491 | $101,548 | 0.01% |
Balboa Wealth Partners | 47,500 | $14,250 | 0.01% |
Waypoint Capital Advisors, LLC | 26,271 | $7,882 | 0.00% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $16,243 | 0.00% |
Aureus Asset Management, LLC | 30,211 | $9,063 | 0.00% |
AXXCESS WEALTH MANAGEMENT, LLC | 70,363 | $21,109 | 0.00% |